OSE Immunotherapeutics SA announced that the company is one of the first biotech startup companies selected by Microsoft France to be a privileged partner of its support program for French Biotech & Deeptech Startups.
[OSE Immunotherapeutics SA]
Home Newsletters Immune Regulation News OSE Immunotherapeutics Announces Collaboration with Microsoft
